Eyenovia, Inc. financial data

Symbol
EYEN on Nasdaq
Industry
Pharmaceutical Preparations
Location
295 Madison Avenue,, Suite 2400, New York, NY
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 143 % -66.8%
Quick Ratio 13.9 %
Debt-to-equity 349 % +290%
Return On Equity -616 % -287%
Return On Assets -137 % -63.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 64.1M shares
Common Stock, Shares, Outstanding 55.8M shares +46.2%
Entity Public Float 88M USD +65.7%
Common Stock, Value, Issued 5.58K USD +46.2%
Weighted Average Number of Shares Outstanding, Basic 53.1M shares +39.5%
Weighted Average Number of Shares Outstanding, Diluted 53.1M shares +39.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 22.6K USD
Cost of Revenue 490K USD
Research and Development Expense 16.7M USD +46.1%
General and Administrative Expense 13.9M USD +10.5%
Operating Income (Loss) -35.9M USD -49.6%
Nonoperating Income (Expense) -1.34M USD
Net Income (Loss) Attributable to Parent -37.3M USD -46.9%
Earnings Per Share, Basic -0.79 USD/shares -16.2%
Earnings Per Share, Diluted -0.79 USD/shares -16.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.3M USD -86.8%
Inventory, Net 3.05M USD
Assets, Current 7.28M USD -68.7%
Property, Plant and Equipment, Net 3.04M USD -17.8%
Operating Lease, Right-of-Use Asset 1.41M USD -26.4%
Intangible Assets, Net (Excluding Goodwill) 6.12M USD
Assets 19M USD -35.3%
Accounts Payable, Current 1.44M USD +9.44%
Employee-related Liabilities, Current 1.28M USD +26.2%
Liabilities, Current 15.8M USD +290%
Operating Lease, Liability, Noncurrent 984K USD -37.9%
Liabilities 21.4M USD +13.5%
Retained Earnings (Accumulated Deficit) -167M USD -28.6%
Stockholders' Equity Attributable to Parent -2.37M USD -123%
Liabilities and Equity 19M USD -35.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -9.89M USD -42.1%
Net Cash Provided by (Used in) Financing Activities 3.13M USD -7.84%
Net Cash Provided by (Used in) Investing Activities -114K USD +86.4%
Common Stock, Shares Authorized 300M shares +233%
Common Stock, Shares, Issued 55.8M shares +46.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -6.87M USD -56.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.3M USD -86.8%
Deferred Tax Assets, Valuation Allowance 30.4M USD +17.5%
Deferred Tax Assets, Gross 31.1M USD +18%
Operating Lease, Liability 1.58M USD -21.3%
Payments to Acquire Property, Plant, and Equipment 114K USD -87.6%
Lessee, Operating Lease, Liability, to be Paid 1.82M USD -29%
Property, Plant and Equipment, Gross 4.79M USD +148%
Operating Lease, Liability, Current 600K USD +40.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 675K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 365K USD -44.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 232K USD -57.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 561K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 23.8M USD +18%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 6M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 215K USD 0%
Operating Lease, Payments 74.1K USD -45.6%
Additional Paid in Capital 165M USD +17.3%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 248K USD +292%
Interest Expense 2.6M USD +53.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%